Amalgamated Bank Decreases Stock Position in Centene Co. (NYSE:CNC)

Amalgamated Bank lowered its holdings in Centene Co. (NYSE:CNC) by 0.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 107,033 shares of the company’s stock after selling 812 shares during the period. Amalgamated Bank’s holdings in Centene were worth $8,057,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Park Place Capital Corp lifted its position in shares of Centene by 1,190.0% during the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after purchasing an additional 357 shares during the last quarter. WR Wealth Planners LLC grew its position in shares of Centene by 41.4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after acquiring an additional 137 shares in the last quarter. Chris Bulman Inc acquired a new stake in shares of Centene during the 2nd quarter valued at approximately $33,000. Riverview Trust Co lifted its stake in Centene by 154.6% during the second quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after purchasing an additional 320 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in Centene in the second quarter worth $36,000. 93.63% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CNC has been the subject of several research reports. JPMorgan Chase & Co. decreased their price target on shares of Centene from $85.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, July 10th. Robert W. Baird cut their target price on Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a research note on Friday, October 25th. Wells Fargo & Company reduced their price target on shares of Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a research note on Monday. Deutsche Bank Aktiengesellschaft raised their target price on Centene from $82.00 to $87.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Finally, Stephens reiterated an “equal weight” rating and set a $78.00 price objective on shares of Centene in a research report on Monday, August 5th. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, Centene has an average rating of “Moderate Buy” and an average target price of $83.92.

Centene Trading Down 3.5 %

CNC stock opened at $62.56 on Thursday. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. The firm has a market cap of $31.58 billion, a P/E ratio of 10.86, a P/E/G ratio of 0.87 and a beta of 0.49. Centene Co. has a 1-year low of $59.77 and a 1-year high of $81.42. The business’s 50 day moving average is $70.40 and its 200-day moving average is $71.75.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.